{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:01:42Z","timestamp":1783400502891,"version":"3.54.6"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Critical limb ischemia (CLI) is the most advanced form of peripheral arterial disease (PAD) characterized by ischemic rest pain and non-healing ulcers. Currently, the standard therapy for CLI is the surgical reconstruction and endovascular therapy or limb amputation for patients with no treatment options. Neovasculogenesis induced by mesenchymal stem cells (MSCs) therapy is a promising approach to improve CLI. Owing to their angiogenic and immunomodulatory potential, MSCs are perfect candidates for the treatment of CLI. The purpose of this study was to determine and compare the in vitro and in vivo effects of allogeneic bone marrow mesenchymal stem cells (BM-MSCs) and adipose tissue mesenchymal stem cells (AT-MSCs) on CLI treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>For the first step, BM-MSCs and AT-MSCs were isolated and characterized for the characteristic MSC phenotypes. Then, femoral artery ligation and total excision of the femoral artery were performed on C57BL\/6 mice to create a CLI model. The cells were evaluated for their in vitro and in vivo biological characteristics for CLI cell therapy. In order to determine these characteristics, the following tests were performed: morphology, flow cytometry, differentiation to osteocyte and adipocyte, wound healing assay, and behavioral tests including Tarlov, Ischemia, Modified ischemia, Function and the grade of limb necrosis scores, donor cell survival assay, and histological analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our cellular and functional tests indicated that during 28\u2009days after cell transplantation, BM-MSCs had a great effect on endothelial cell migration, muscle restructure, functional improvements, and neovascularization in ischemic tissues compared with AT-MSCs and control groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Allogeneic BM-MSC transplantation resulted in a more effective recovery from critical limb ischemia compared to AT-MSCs transplantation. In fact, BM-MSC transplantation could be considered as a promising therapy for diseases with insufficient angiogenesis including hindlimb ischemia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-020-02110-x","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T01:02:42Z","timestamp":1610499762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy"],"prefix":"10.1186","volume":"12","author":[{"given":"Pegah","family":"Nammian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh-Leili","family":"Asadi-Yousefabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Daneshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hasan","family":"Sheikhha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad Bagher","family":"Tabei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-6081","authenticated-orcid":false,"given":"Vahid","family":"Razban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"issue":"6","key":"2110_CR1","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","volume":"62","author":"AMA Dabrh","year":"2015","unstructured":"Dabrh AMA, Steffen MW, Undavalli C, Asi N, Wang Z, Elamin MB, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62(6):1642\u201351. e3.","journal-title":"J Vasc Surg"},{"issue":"2","key":"2110_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/0003319714523113","volume":"66","author":"H Hioki","year":"2015","unstructured":"Hioki H, Miyashita Y, Miura T, Ebisawa S, Motoki H, Izawa A, et al. Prognostic improvement by multidisciplinary therapy in patients with critical limb ischemia. Angiology. 2015;66(2):187\u201394.","journal-title":"Angiology."},{"issue":"3","key":"2110_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/01.cir.0000442015.53336.12","volume":"129","author":"AS Go","year":"2014","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Executive summary: heart disease and stroke statistics\u20142014 update: a report from the American Heart Association. Circulation. 2014;129(3):399\u2013410.","journal-title":"Circulation."},{"issue":"9","key":"2110_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.115.303565","volume":"116","author":"JP Cooke","year":"2015","unstructured":"Cooke JP, Losordo DW. Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ Res. 2015;116(9):1561\u201378.","journal-title":"Circ Res"},{"issue":"9501","key":"2110_CR5","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","volume":"366","author":"A Bradbury","year":"2005","unstructured":"Bradbury A, Ruckley C, Fowkes F, Forbes J, Gillespie I, Adam D. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925\u201334.","journal-title":"Lancet."},{"issue":"14","key":"2110_CR6","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jacc.2013.01.004","volume":"61","author":"JL Anderson","year":"2013","unstructured":"Anderson JL, Halperin JL, Albert N, Bozkurt B, Brindis RG, Curtis LH, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA guideline recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(14):1555\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2110_CR7","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31822e80c3","volume":"124","author":"TW Rooke","year":"2011","unstructured":"Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) a report of the American college of cardiology foundation\/American heart association task force on practice guidelines. Circulation. 2011;124(18):2020\u201345.","journal-title":"Circulation."},{"issue":"15","key":"2110_CR8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/ehv006","volume":"36","author":"H Reinecke","year":"2015","unstructured":"Reinecke H, Unrath M, Freisinger E, Bunzemeier H, Meyborg M, Lueders F, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36(15):932\u20138.","journal-title":"Eur Heart J"},{"key":"2110_CR9","doi-asserted-by":"crossref","unstructured":"Shimamura M, Nakagami H, Koriyama H, Morishita R. Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease. Biomed Res Int. 2013;2013. https:\/\/www.hindawi.com\/journals\/bmri\/2013\/186215\/.","DOI":"10.1155\/2013\/186215"},{"issue":"3","key":"2110_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3103\/S0095452718030064","volume":"52","author":"V Razban","year":"2018","unstructured":"Razban V, Khajeh S, Alaee S, Mostafavi-Pour Z, Soleimani M. Tube formation potential of BMSCs and USSCs in response to HIF-1\u03b1 overexpression under hypoxia. Cytol Genet. 2018;52(3):236\u201344.","journal-title":"Cytol Genet"},{"issue":"9331","key":"2110_CR11","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0140-6736(02)09670-8","volume":"360","author":"E Tateishi-Yuyama","year":"2002","unstructured":"Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360(9331):427\u201335.","journal-title":"Lancet"},{"issue":"5","key":"2110_CR12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1089\/rej.2009.0872","volume":"12","author":"NR Dash","year":"2009","unstructured":"Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009;12(5):359\u201366.","journal-title":"Rejuvenation Res"},{"issue":"18","key":"2110_CR13","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1093\/eurheartj\/ehi285","volume":"26","author":"K Lenk","year":"2005","unstructured":"Lenk K, Adams V, Lurz P, Erbs S, Linke A, Gielen S, et al. Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia. Eur Heart J. 2005;26(18):1903\u20139.","journal-title":"Eur Heart J"},{"issue":"10","key":"2110_CR14","first-page":"351","volume":"63","author":"R Nizankowski","year":"2005","unstructured":"Nizankowski R, Petriczek T, Skotnicki A, Szczeklik A. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiol Pol. 2005;63(10):351.","journal-title":"Kardiol Pol"},{"issue":"11","key":"2110_CR15","doi-asserted-by":"publisher","first-page":"e54-e","DOI":"10.1038\/emm.2013.94","volume":"45","author":"MB Murphy","year":"2013","unstructured":"Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med. 2013;45(11):e54-e.","journal-title":"Exp Mol Med"},{"issue":"4","key":"2110_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/scrt119","volume":"3","author":"A Liew","year":"2012","unstructured":"Liew A, O'Brien T. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia. Stem Cell Res Ther. 2012;3(4):28.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"2110_CR17","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0b013e3182854cf1","volume":"258","author":"M Teraa","year":"2013","unstructured":"Teraa M, Sprengers RW, van der Graaf Y, Peters CE, Moll FL, Verhaar MC. Autologous bone marrow\u2013derived cell therapy in patients with critical limb ischemia: a meta-analysis of randomized controlled clinical trials. Ann Surg. 2013;258(6):922\u20139.","journal-title":"Ann Surg"},{"issue":"7","key":"2110_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2478\/s11756-018-0080-z","volume":"73","author":"S Khajeh","year":"2018","unstructured":"Khajeh S, Razban V, Talaei-Khozani T, Soleimani M, Asadi-Golshan R, Dehghani F, et al. Enhanced chondrogenic differentiation of dental pulp-derived mesenchymal stem cells in 3D pellet culture system: effect of mimicking hypoxia. Biologia. 2018;73(7):715\u201326.","journal-title":"Biologia."},{"key":"2110_CR19","doi-asserted-by":"crossref","unstructured":"Teraa M, Sprengers RW, Westerweel PE, Gremmels H, Goumans M-JT, Teerlink T, et al. Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients. PloS one. 2013;8(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/23383236\/.","DOI":"10.1371\/journal.pone.0055592"},{"issue":"6","key":"2110_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/scrt351","volume":"4","author":"H Gremmels","year":"2013","unstructured":"Gremmels H, Fledderus JO, Teraa M, Verhaar MC. Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective. Stem Cell Res Ther. 2013;4(6):140.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"2110_CR21","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jcyt.2013.01.010","volume":"15","author":"ME Reinders","year":"2013","unstructured":"Reinders ME, Roemeling-van Rhijn M, Khairoun M, Lievers E, de Vries DK, Schaapherder AF, et al. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy. Cytotherapy. 2013;15(6):663\u201372.","journal-title":"Cytotherapy."},{"issue":"10","key":"2110_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1166\/jbt.2014.1234","volume":"4","author":"V Razban","year":"2014","unstructured":"Razban V, Khajeh S, Lotfi AS, Mohsenifar A, Soleimani M, Khoshdel A, et al. Engineered heparan sulfate-collagen IV surfaces improve human mesenchymal stem cells differentiation to functional hepatocyte-like cells. J Biomater Tissue Eng. 2014;4(10):811\u201322.","journal-title":"J Biomater Tissue Eng"},{"key":"2110_CR23","doi-asserted-by":"crossref","unstructured":"Altaner C, Altanerova V, Cihova M, Hunakova L, Kaiserova K, Klepanec A, et al. Characterization of mesenchymal stem cells of \u201cno-options\u201d patients with critical limb ischemia treated by autologous bone marrow mononuclear cells. Plos One. 2013;8(9). https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3771988\/.","DOI":"10.1371\/journal.pone.0073722"},{"issue":"1\u20132","key":"2110_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jneuroim.2010.07.013","volume":"227","author":"B Yamout","year":"2010","unstructured":"Yamout B, Hourani R, Salti H, Barada W, El-Hajj T, Al-Kutoubi A, et al. Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J Neuroimmunol. 2010;227(1\u20132):185\u20139.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"2110_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1089\/scd.2018.0090","volume":"28","author":"E Cortez-Toledo","year":"2019","unstructured":"Cortez-Toledo E, Rose M, Agu E, Dahlenburg H, Yao W, Nolta JA, et al. Enhancing retention of human bone marrow mesenchymal stem cells with prosurvival factors promotes angiogenesis in a mouse model of limb ischemia. Stem Cells Dev. 2019;28(2):114\u20139.","journal-title":"Stem Cells Dev"},{"key":"2110_CR26","doi-asserted-by":"crossref","unstructured":"Mohamed SA, Howard L, McInerney V, Hayat A, Krawczyk J, Naughton S, et al. Autologous bone marrow mesenchymal stromal cell therapy for \u201cno-option\u201d critical limb ischemia is limited by karyotype abnormalities. Cytotherapy. 2020. https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1465324920300621.","DOI":"10.1016\/j.jcyt.2020.02.007"},{"issue":"1","key":"2110_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/VIT.VIT_7_20","volume":"3","author":"L Liao","year":"2020","unstructured":"Liao L. Cell therapy of critical limb ischemia: a review of preclinical and clinical research in China. Vasc Invest Ther. 2020;3(1):21.","journal-title":"Vasc Invest Ther"},{"key":"2110_CR28","unstructured":"Beugels J, De Munter J, Van der Hulst R, Kramer B, Wolters E. Efficacy of different doses of human autologous adult bone mar-row stem cell transplantation on angiogenesis in an immune deficient rat model with hind limb ischemia. J Stem Cell Res Dev Ther. 2019;S1002. https:\/\/www.heraldopenaccess.us\/openaccess\/efficacy-of-different-doses-of-human-autologous-adultbone-marrow-stem-cell-transplantation-on-angiogenesis-in-an-immune-deficient-rat-model-withhind-limb-ischemia."},{"key":"2110_CR29","doi-asserted-by":"crossref","unstructured":"van Rhijn-Brouwer FC, van Balkom BW, Papazova DA, Hazenbrink DH, Meijer AJ, Brete I, et al. Paracrine proangiogenic function of human bone marrow-derived mesenchymal stem cells is not affected by chronic kidney disease. Stem Cells Int. 2019;2019. https:\/\/pubmed.ncbi.nlm.nih.gov\/31933648\/.","DOI":"10.1155\/2019\/1232810"},{"issue":"2","key":"2110_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jcyt.2013.11.011","volume":"16","author":"A Bura","year":"2014","unstructured":"Bura A, Planat-Benard V, Bourin P, Silvestre J-S, Gross F, Grolleau J-L, et al. Phase I trial: the use of autologous cultured adipose-derived stroma\/stem cells to treat patients with non-revascularizable critical limb ischemia. Cytotherapy. 2014;16(2):245\u201357.","journal-title":"Cytotherapy."},{"issue":"8","key":"2110_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4252\/wjsc.v9.i8.107","volume":"9","author":"RT Qomi","year":"2017","unstructured":"Qomi RT, Sheykhhasan M. Adipose-derived stromal cell in regenerative medicine: a review. World J Stem Cells. 2017;9(8):107.","journal-title":"World J Stem Cells"},{"issue":"3","key":"2110_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/wrr.12173","volume":"22","author":"WU Hassan","year":"2014","unstructured":"Hassan WU, Greiser U, Wang W. Role of adipose-derived stem cells in wound healing. Wound Repair Regen. 2014;22(3):313\u201325.","journal-title":"Wound Repair Regen"},{"issue":"3","key":"2110_CR33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0268355516641546","volume":"32","author":"I Zollino","year":"2017","unstructured":"Zollino I, Zuolo M, Gianesini S, Pedriali M, Sibilla MG, Tessari M, et al. Autologous adipose-derived stem cells: basic science, technique, and rationale for application in ulcer and wound healing. Phlebology. 2017;32(3):160\u201371.","journal-title":"Phlebology."},{"key":"2110_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-94-017-8032-2_15","volume":"12","author":"H Mizuno","year":"2014","unstructured":"Mizuno H, Tobita M, Orbay H, Uysal AC, Lu F. Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells Cancer Stem Cells. 2014;12:165\u201374.","journal-title":"Stem Cells Cancer Stem Cells"},{"issue":"3","key":"2110_CR35","first-page":"H1020","volume":"297","author":"L Wang","year":"2009","unstructured":"Wang L, Deng J, Tian W, Xiang B, Yang T, Li G, et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Phys Heart Circ Phys. 2009;297(3):H1020\u2013H31.","journal-title":"Am J Phys Heart Circ Phys"},{"issue":"12","key":"2110_CR36","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1161\/01.ATV.0000190701.92007.6d","volume":"25","author":"H Nakagami","year":"2005","unstructured":"Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue\u2013derived stromal cells. Arterioscler Thromb Vasc Biol. 2005;25(12):2542\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2110_CR37","doi-asserted-by":"crossref","unstructured":"Fan W, Sun D, Liu J, Liang D, Wang Y, Narsinh KH, et al. Adipose stromal cells amplify angiogenic signaling via the VEGF\/mTOR\/Akt pathway in a murine hindlimb ischemia model: a 3D multimodality imaging study. Plos one. 2012;7(9). https:\/\/pubmed.ncbi.nlm.nih.gov\/23029141\/.","DOI":"10.1371\/journal.pone.0045621"},{"issue":"5\u20136","key":"2110_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000094140","volume":"17","author":"MH Moon","year":"2006","unstructured":"Moon MH, Kim SY, Kim YJ, Kim SJ, Lee JB, Bae YC, et al. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem. 2006;17(5\u20136):279\u201390.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"2110_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3390\/jcm7040082","volume":"7","author":"L Haghighat","year":"2018","unstructured":"Haghighat L, Altin SE, Attaran RR, Mena-Hurtado C, Regan CJ. Review of the latest percutaneous devices in critical limb ischemia. J Clin Med. 2018;7(4):82.","journal-title":"J Clin Med"},{"issue":"1","key":"2110_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/1708538118797782","volume":"27","author":"J Bath","year":"2019","unstructured":"Bath J, Kim RJ, Dombrovskiy VY, Vogel TR. Contemporary trends and outcomes of thrombolytic therapy for acute lower extremity ischemia. Vascular. 2019;27(1):71\u20137.","journal-title":"Vascular."},{"key":"2110_CR41","doi-asserted-by":"crossref","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy. 2006;8(4):315\u2013317.","DOI":"10.1080\/14653240600855905"},{"key":"2110_CR42","doi-asserted-by":"crossref","unstructured":"Tao H, Han Z, Han ZC, Li Z. Proangiogenic features of mesenchymal stem cells and their therapeutic applications. Stem Cells Int. 2016;2016. https:\/\/www.hindawi.com\/journals\/sci\/2016\/1314709\/.","DOI":"10.1155\/2016\/1314709"},{"key":"2110_CR43","doi-asserted-by":"crossref","unstructured":"Maacha S, Sidahmed H, Jacob S, Gentilcore G, Calzone R, Grivel J-C, et al. Paracrine mechanisms of mesenchymal stromal cells in angiogenesis. Stem Cells Int. 2020;2020. https:\/\/www.hindawi.com\/journals\/sci\/2020\/4356359\/.","DOI":"10.1155\/2020\/4356359"},{"issue":"1","key":"2110_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-60352-4","volume":"10","author":"SM Krishna","year":"2020","unstructured":"Krishna SM, Omer SM, Li J, Morton SK, Jose RJ, Golledge J. Development of a two-stage limb ischemia model to better simulate human peripheral artery disease. Sci Rep. 2020;10(1):1\u201316.","journal-title":"Sci Rep"},{"issue":"4","key":"2110_CR45","first-page":"1","volume":"50","author":"I Kang","year":"2018","unstructured":"Kang I, Lee B-C, Choi SW, Lee JY, Kim J-J, Kim B-E, et al. Donor-dependent variation of human umbilical cord blood mesenchymal stem cells in response to hypoxic preconditioning and amelioration of limb ischemia. Exp Mol Med. 2018;50(4):1\u201315.","journal-title":"Exp Mol Med"},{"issue":"6","key":"2110_CR46","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.jvs.2012.04.067","volume":"56","author":"RA Brenes","year":"2012","unstructured":"Brenes RA, Jadlowiec CC, Bear M, Hashim P, Protack CD, Li X, et al. Toward a mouse model of hind limb ischemia to test therapeutic angiogenesis. J Vasc Surg. 2012;56(6):1669\u201379.","journal-title":"J Vasc Surg"},{"issue":"2","key":"2110_CR47","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jvs.2008.08.077","volume":"49","author":"TS Westvik","year":"2009","unstructured":"Westvik TS, Fitzgerald TN, Muto A, Maloney SP, Pimiento JM, Fancher TT, et al. Limb ischemia after iliac ligation in aged mice stimulates angiogenesis without arteriogenesis. J Vasc Surg. 2009;49(2):464\u201373.","journal-title":"J Vasc Surg"},{"key":"2110_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.5114\/fn.2018.76615","volume":"56","author":"W Hu","year":"2018","unstructured":"Hu W, Jiang J, Yang F, Liu J. The impact of bone marrow-derived mesenchymal stem cells on neovascularisation in rats with brain injury. Folia Neuropathol. 2018;56:112\u201323.","journal-title":"Folia Neuropathol"},{"issue":"2","key":"2110_CR49","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3892\/ol.2015.3997","volume":"11","author":"GC Li","year":"2016","unstructured":"Li GC, Zhang HW, Zhao QC, Sun L, Yang JJ, Hong L, et al. Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor \u03b21. Oncol Lett. 2016;11(2):1089\u201394.","journal-title":"Oncol Lett"},{"issue":"10","key":"2110_CR50","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","volume":"25","author":"Y Wu","year":"2007","unstructured":"Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25(10):2648\u201359.","journal-title":"Stem Cells"},{"issue":"1","key":"2110_CR51","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.yexcr.2016.04.013","volume":"344","author":"C-C Shen","year":"2016","unstructured":"Shen C-C, Chen B, Gu J-T, Ning J-L, Chen L, Zeng J, et al. The angiogenic related functions of bone marrow mesenchymal stem cells are promoted by CBDL rat serum via the Akt\/Nrf2 pathway. Exp Cell Res. 2016;344(1):86\u201394.","journal-title":"Exp Cell Res"},{"issue":"40","key":"2110_CR52","doi-asserted-by":"publisher","first-page":"42825","DOI":"10.18632\/oncotarget.5739","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Wang Y, Wang S, Cai J, Shi J, Sui X, et al. Bone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer. Oncotarget. 2015;6(40):42825.","journal-title":"Oncotarget."},{"issue":"21","key":"2110_CR53","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1161\/01.CIR.0000102939.04279.75","volume":"108","author":"NP Fam","year":"2003","unstructured":"Fam NP, Verma S, Kutryk M, Stewart DJ. Clinician guide to angiogenesis. Circulation. 2003;108(21):2613\u20138.","journal-title":"Circulation."},{"issue":"22","key":"2110_CR54","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1016\/j.biomaterials.2014.03.067","volume":"35","author":"X Li","year":"2014","unstructured":"Li X, Zhou J, Liu Z, Chen J, L\u00fc S, Sun H, et al. A PNIPAAm-based thermosensitive hydrogel containing SWCNTs for stem cell transplantation in myocardial repair. Biomaterials. 2014;35(22):5679\u201388.","journal-title":"Biomaterials."},{"issue":"2","key":"2110_CR55","doi-asserted-by":"publisher","first-page":"e002815","DOI":"10.1161\/JAHA.115.002815","volume":"5","author":"N Tano","year":"2016","unstructured":"Tano N, Kaneko M, Ichihara Y, Ikebe C, Coppen SR, Shiraishi M, et al. Allogeneic mesenchymal stromal cells transplanted onto the heart surface achieve therapeutic myocardial repair despite immunologic responses in rats. J Am Heart Assoc. 2016;5(2):e002815.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2110_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-019-1156-6","volume":"10","author":"L Salda\u00f1a","year":"2019","unstructured":"Salda\u00f1a L, Bensiamar F, Vall\u00e9s G, Mancebo FJ, Garc\u00eda-Rey E, Vilaboa N. Immunoregulatory potential of mesenchymal stem cells following activation by macrophage-derived soluble factors. Stem Cell Res Ther. 2019;10(1):1\u201315.","journal-title":"Stem Cell Res Ther"},{"key":"2110_CR57","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","volume":"10","author":"ARR Weiss","year":"2019","unstructured":"Weiss ARR, Dahlke MH. Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs. Front Immunol. 2019;10:1191.","journal-title":"Front Immunol"},{"issue":"1","key":"2110_CR58","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.biomaterials.2013.09.083","volume":"35","author":"M Ara\u00f1a","year":"2014","unstructured":"Ara\u00f1a M, Gavira JJ, Pe\u00f1a E, Gonz\u00e1lez A, Abizanda G, Cilla M, et al. Epicardial delivery of collagen patches with adipose-derived stem cells in rat and minipig models of chronic myocardial infarction. Biomaterials. 2014;35(1):143\u201351.","journal-title":"Biomaterials."},{"issue":"12","key":"2110_CR59","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/sctm.17-0129","volume":"6","author":"RM Samsonraj","year":"2017","unstructured":"Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM. Concise review: multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med. 2017;6(12):2173\u201385.","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"2110_CR60","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1002\/stem.2612","volume":"35","author":"SE Sherman","year":"2017","unstructured":"Sherman SE, Kuljanin M, Cooper TT, Putman DM, Lajoie GA, Hess DA. High aldehyde dehydrogenase activity identifies a subset of human mesenchymal stromal cells with vascular regenerative potential. Stem Cells. 2017;35(6):1542\u201353.","journal-title":"Stem Cells"},{"issue":"4","key":"2110_CR61","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/scrt245","volume":"4","author":"FF Cunha","year":"2013","unstructured":"Cunha FF, Martins L, Martin PKM, Stilhano RS, Han SW. A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB\/c and C57\/BL6 mice in a model of limb ischemia. Stem Cell Res Ther. 2013;4(4):86.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"2110_CR62","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/biof.1563","volume":"45","author":"SA Muhammad","year":"2019","unstructured":"Muhammad SA. Mesenchymal stromal cell secretome as a therapeutic strategy for traumatic brain injury. BioFactors. 2019;45(6):880\u201391.","journal-title":"BioFactors."},{"issue":"3","key":"2110_CR63","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.biocel.2012.12.001","volume":"45","author":"M Choi","year":"2013","unstructured":"Choi M, Lee H-S, Naidansaren P, Kim H-K, Eunju O, Cha J-H, et al. Proangiogenic features of Wharton's jelly-derived mesenchymal stromal\/stem cells and their ability to form functional vessels. Int J Biochem Cell Biol. 2013;45(3):560\u201370.","journal-title":"Int J Biochem Cell Biol"},{"issue":"8","key":"2110_CR64","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1177\/0271678X18776802","volume":"38","author":"CJ Cunningham","year":"2018","unstructured":"Cunningham CJ, Redondo-Castro E, Allan SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke. J Cereb Blood Flow Metab. 2018;38(8):1276\u201392.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2110_CR65","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/cells9020312","volume":"9","author":"G Merckx","year":"2020","unstructured":"Merckx G, Hosseinkhani B, Kuypers S, Deville S, Irobi J, Nelissen I, et al. Angiogenic effects of human dental pulp and bone marrow-derived mesenchymal stromal cells and their extracellular vesicles. Cells. 2020;9(2):312.","journal-title":"Cells."},{"issue":"6","key":"2110_CR66","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4252\/wjsc.v11.i6.347","volume":"11","author":"U Kozlowska","year":"2019","unstructured":"Kozlowska U, Krawczenko A, Futoma K, Jurek T, Rorat M, Patrzalek D, et al. Similarities and differences between mesenchymal stem\/progenitor cells derived from various human tissues. World J Stem Cells. 2019;11(6):347.","journal-title":"World J Stem Cells."},{"issue":"1","key":"2110_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-61167-z","volume":"10","author":"Y Petrenko","year":"2020","unstructured":"Petrenko Y, Vackova I, Kekulova K, Chudickova M, Koci Z, Turnovcova K, et al. A comparative analysis of multipotent mesenchymal stromal cells derived from different sources, with a focus on neuroregenerative potential. Sci Rep. 2020;10(1):1\u201315.","journal-title":"Sci Rep"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02110-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-02110-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02110-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T01:44:52Z","timestamp":1674870292000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-02110-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2110"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-02110-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"3 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures and use of research animals in this study were approved by the Shiraz University of Medical Sciences ethics committee (1397.430).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}